Existing GERD, gastroparesis, or IBS place you in the higher side-effect-risk column, while having no history of IBS or chronic reflux points the other way
Some GLP-1 receptor agonists, like Tirzepatide, have been shown to reduce the risk of major cardiovascular events (e.g., heart attack, stroke) in people with Type 2 diabetes and existing heart disease
If you are taking insulin or sulfonylureas, tirzepatide can increase the risk of hypoglycemia
This advanced metabolic support formulation features branded and clinically studied ingredients recognized within the nutrition and functional medicine industries
This is the first time the rate has declined by more than 1 point between survey periods
Other names you might have heard include exenatide (Byetta, Bydureon), liraglutide (Victoza, Saxenda), and dulaglutide (Trulicity)